AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 23103035
Drug: Long-term PM(2.5)
RxNorm normalized name: benzethonium
DrugBank: Benzethonium (DB11125)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Long-term PM(2.5) exposure (3 μg/m(3) increase)
Trial: 23103035
Drug: Short-term PM(2.5)
RxNorm normalized name: hydrogen peroxide
DrugBank: Hydrogen peroxide (DB11091)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Short-term PM(2.5) exposure (12 μg/m(3) daily increase)
Trial: 17496489
Drug: Trimetazidine, 20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trimetazidine, 20 mg three times daily for 12 weeks
Trial: 11977538
Drug: Dietary guidance
RxNorm normalized name: sodium phosphate, monobasic
DrugBank: Sodium phosphate, monobasic (DB09449)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dietary guidance and ingestion of aged garlic extract (AGE) capsules
Trial: 11977538
Drug: Dietary guidance
RxNorm normalized name: sodium phosphate, monobasic
DrugBank: Sodium phosphate, monobasic (DB09449)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dietary guidance and non‐function capsules
Trial: 9846676
Drug: Transdermal oestrogens
RxNorm normalized name: estrogens
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal oestrogens 50 microg, 2 patches/week for 3 weeks per month, plus acetate nomegestrolo per os 5 mg/die for 12 days per cycle (Group A)
Trial: 9846676
Drug: Tibolone 2.5
RxNorm normalized name: tibolone 2.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tibolone 2.5 mg/die (Group B)
Trial: 9846676
Drug: No medication
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No medication (Control Group C)
Trial: 8137201
Drug: Chemotherapy and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy and radiation therapy (CRT) - 20 Gy and two courses of 5-FU and cisplatin
Trial: 1262709
Drug: Freshly harvested
RxNorm normalized name: lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Freshly harvested vaccine (3 x 10(10)‐10(11) organisms/dose)
Trial: 1262709
Drug: Fresh vaccine
RxNorm normalized name: Peroxi-Fresh
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fresh vaccine
Trial: 31169793
Drug: HIGH carbohydrate
RxNorm normalized name: High carbohydrate food
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HIGH carbohydrate intake (8 g·kg body mass)
Trial: 31169793
Drug: LOW carbohydrate
RxNorm normalized name: Low carbohydrate beer
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LOW carbohydrate intake (3 g·kg body mass)
Trial: 23446963
Drug: Fortified food
RxNorm normalized name: fortified food
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fortified food supplement (SG)
Trial: 23446963
Drug: No food
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No food supplement (NSG)
Trial: 21693443
Drug: Hyalograft‐3D autograft
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hyalograft‐3D autograft followed by Laserskin autograft after 2 weeks (treatment group)
Trial: 18952009
Drug: Topical l-NAME
RxNorm normalized name: L-NAME
DrugBank: N-omega-nitro-L-arginine methyl ester (DB12750)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical l-NAME (NO synthase inhibitor)
Trial: 18952009
Drug: Inhalation
RxNorm normalized name: INHALATION GAS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhalation
Trial: 17227571
Drug: Losartan (50-100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Losartan (50-100 mg daily)
Trial: 17227571
Drug: Carvedilol (12.5-25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carvedilol (12.5-25 mg)
Trial: 16083171
Drug: Continuous ultrasound
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous ultrasound therapy with intensity of 0.5 W/cm2 applied to the palmar carpal tunnel for 10 minutes, 5 days a week for 4 weeks.
Trial: 16083171
Drug: Sham ultrasound
RxNorm normalized name: ULTRASOUND
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sham ultrasound and Diclofenac 75 mg/day in divided doses.
Trial: 2418304
Drug: HOE 498
RxNorm normalized name: CASTOR OIL 3 mg in 30 mg / ROSEMARY 4.5 mg in 30 mg / TOCOPHEROL 9 mg in 30 mg TOPICAL LIQUID [HOEGOA Herbal Hair Growth OiI]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HOE 498 (2.5 mg)
Trial: 2418304
Drug: HOE 498
RxNorm normalized name: CASTOR OIL 3 mg in 30 mg / ROSEMARY 4.5 mg in 30 mg / TOCOPHEROL 9 mg in 30 mg TOPICAL LIQUID [HOEGOA Herbal Hair Growth OiI]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HOE 498 (5 mg)
Trial: 2418304
Drug: HOE 498
RxNorm normalized name: CASTOR OIL 3 mg in 30 mg / ROSEMARY 4.5 mg in 30 mg / TOCOPHEROL 9 mg in 30 mg TOPICAL LIQUID [HOEGOA Herbal Hair Growth OiI]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HOE 498 (10 mg)
Trial: 2418304
Drug: HOE 498
RxNorm normalized name: CASTOR OIL 3 mg in 30 mg / ROSEMARY 4.5 mg in 30 mg / TOCOPHEROL 9 mg in 30 mg TOPICAL LIQUID [HOEGOA Herbal Hair Growth OiI]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HOE 498 (various doses)
Trial: 21448918
Drug: Alendronate 70
RxNorm normalized name: ALENDRONATE 70MG TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alendronate 70 mg plus vitamin D(3) 2800 IU (ALN + D)
Trial: 16813472
Drug: Fractionated walking
RxNorm normalized name: LIVER FRACTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fractionated walking (2 daily sessions)
Trial: 12944249
Drug: Dark chocolate
RxNorm normalized name: Ensure Original Dark Chocolate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dark chocolate (100 g)
Trial: 12944249
Drug: White chocolate
RxNorm normalized name: chocolate allergenic extract
DrugBank: Cocoa (DB10977)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: White chocolate (100 g)
Trial: 12944249
Drug: Milk chocolate
RxNorm normalized name: Meritene Milk Chocolate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Milk chocolate (100 g)
Trial: 1678316
Drug: Bopindolol (B)
RxNorm normalized name: bopindolol
DrugBank: Bopindolol (DB08807)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bopindolol (B) 2 mg once daily after initial 1 mg for 4 weeks
Trial: 1678316
Drug: Diltiazem (D)
DrugBank: Diltiazem (DB00343)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Diltiazem (D) 240 mg in 4 divided doses after initial 120 mg
Trial: 26384091
Drug: Berberis aristata/Silybum
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Berberis aristata/Silybum marianum (B. aristata/S. marianum) 588/105 mg, 1 tablet at lunch and 1 tablet at dinner for six months
Trial: 26348588
Drug: Combined intervention
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined intervention (psychoeducation plus medication)
Trial: 25300245
Drug: Treatment-as-usual (medication)
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment-as-usual (medication)
Trial: 19642717
Drug: 5% lidocaine
RxNorm normalized name: LIDOCAINE 5 g in 100 g TOPICAL CREAM [Healcome Tattoo Numbing Cream 5% Lidocaine]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5% lidocaine for 10 minutes (injection of local anesthetic)
Trial: 9799060
Drug: Omeprazole treatment
RxNorm normalized name: Omeprazole
DrugBank: Omeprazole (DB00338)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Omeprazole treatment (20 mg for 4 days) with enteric-coated sodium salicylate tablets
Trial: 9799060
Drug: Uncoated acetylsalicylic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Uncoated acetylsalicylic acid tablets
Trial: 10517036
Drug: Massage therapy
RxNorm normalized name: CAMPHOR (SYNTHETIC) 30 g in 1 mL / MENTHOL 40 g in 1 mL TOPICAL OIL [CBDMEDIC MASSAGE THERAPY]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Massage therapy (20-minute sessions of shoulder, neck, head, and facial massage)
Trial: 6347117
Drug: Gradual withdrawal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gradual withdrawal (group G)
Trial: 25737375
Drug: Intravenous antimicrobial
RxNorm normalized name: GAUZE,ANTIMICROBIAL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous antimicrobial prophylaxis alone (control)
Trial: 1633070
Drug: Ketoconazole 200
RxNorm normalized name: ketoconazole 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketoconazole 200 mg twice daily
Trial: 6428911
Drug: Ouabain 0.5
RxNorm normalized name: ouabain 0.5 mg/2 mL INJECTION AMPUL (ML)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ouabain 0.5 mg i.v.
Trial: 45539
Drug: Nitroglycerin 0.8
RxNorm normalized name: nitroglycerin 0.8 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nitroglycerin 0.8 mg sublingual
Trial: 6428911
Drug: Ouabain 12
RxNorm normalized name: ouabain
DrugBank: Ouabain (DB01092)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ouabain 12 mg sublingual
Trial: 30532195
Drug: NMES on
RxNorm normalized name: Gel-One
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NMES on medial gastrocnemius muscle (NMES-MG)
Trial: 27845159
Drug: Continuous use
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous use of non-menthol combustible cigarettes (CC arm)
Trial: 21335358
Drug: 25 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25 mg of MK-0249 (H3RIA)
Trial: 21335358
Drug: Stable alcohol
RxNorm normalized name: Alcohol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Stable alcohol level (0.6 g L(‐1))
Trial: 18057478
Drug: Full dose
RxNorm normalized name: BayRHo-D Full Dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Full dose candy (vitamin A 1000 IU and 14 mg elemental iron) daily
Trial: 18057478
Drug: Full dose
RxNorm normalized name: BayRHo-D Full Dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Full dose candy for 3 days a week
Trial: 18057478
Drug: Half dose
RxNorm normalized name: propranolol hydrochloride Extended Release Oral Capsule [Half-Betadur CR]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Half dose candy (vitamin A 500 IU and 7 mg elemental iron) daily
Trial: 16327947
Drug: DHEP/heparin (Flector
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DHEP/heparin (Flector Tissugel Heparin)
Trial: 9809958
Drug: Intravenous administration
RxNorm normalized name: intravenous administration set
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous administration of 2% dodecafluoropentane emulsion (EchoGen)
Trial: 2535086
Drug: Continuous epidural
RxNorm normalized name: ACCU-BLOC PERIFIX CONTINUOUS EPIDURAL ANESTHESIA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous epidural analgesia with bupivacaine 0.125% and sufentanil 0.83 micrograms.ml‐1
Trial: 2535086
Drug: Intravenous peroperative
RxNorm normalized name: povidone-iodine
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous peroperative and on-demand intramuscular postoperative analgesia with nicomorphine 0.2 mg.kg‐1
Trial: 31815649
Drug: Upadacitinib 15
RxNorm normalized name: upadacitinib 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Upadacitinib 15 mg daily
Trial: 31815649
Drug: Upadacitinib 30
RxNorm normalized name: upadacitinib 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Upadacitinib 30 mg daily
Trial: 31407810
Drug: Subcutaneous Nexvax2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous Nexvax2 (900 µg)
Trial: 31407810
Drug: Intravenous Nexvax2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous Nexvax2 (900 µg)
Trial: 21471773
Drug: Sildenafil (initial
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sildenafil (initial dose of 50 mg, adjustable to 25 or 100 mg)
Trial: 16158312
Drug: Oral topotecan
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral topotecan (1.2 mg/m2) once a day for 10 days
Trial: 16158312
Drug: Oral topotecan
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral topotecan (1.2 mg/m2) twice a day for 5 days
Trial: 16158312
Drug: Twice a
RxNorm normalized name: Pataday Twice A Day Relief
DrugBank: Olopatadine (DB00768)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Twice a day dosing of topotecan
Trial: 16158312
Drug: Once a
RxNorm normalized name: Once A Day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Once a day dosing of topotecan
Trial: 9394980
Drug: Acidic hot-spring
RxNorm normalized name: Red Hot
DrugBank: Capsaicin (DB06774)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Acidic hot-spring bathing (10-min bath at 42 degrees C, twice daily)
Trial: 8071832
Drug: Ceftibuten (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ceftibuten (400 mg every 12 h for 8 days)
Trial: 29288545
Drug: Lorcaserin (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lorcaserin (10 mg twice a day)
Trial: 25718355
Drug: 24-month dual-antiplatelet
RxNorm normalized name: miconazole
DrugBank: Miconazole (DB01110)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: 24-month dual-antiplatelet therapy (DAPT) in ACS patients
Trial: 25718355
Drug: 6-month dual-antiplatelet
RxNorm normalized name: leuprolide
DrugBank: Leuprolide (DB00007)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6-month dual-antiplatelet therapy (DAPT) in ACS patients
Trial: 25718355
Drug: 24-month dual-antiplatelet
RxNorm normalized name: miconazole
DrugBank: Miconazole (DB01110)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: 24-month dual-antiplatelet therapy (DAPT) in SCAD patients
Trial: 25718355
Drug: 6-month dual-antiplatelet
RxNorm normalized name: leuprolide
DrugBank: Leuprolide (DB00007)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6-month dual-antiplatelet therapy (DAPT) in SCAD patients
Trial: 22323747
Drug: varenicline (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: varenicline (1 mg twice daily for 4 weeks after 4 weeks of titration)
Trial: 15983534
Drug: Isoflavones (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isoflavones (5 mg/kg body weight)
Trial: 15983534
Drug: Vitamin C
RxNorm normalized name: Vitamin C
DrugBank: Sodium ascorbate (DB14482)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin C (500 mg) plus isoflavones (5 mg/kg body weight)
Trial: 12027856
Drug: Group LBH
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group LBH (2.5 ml lignocaine 2%, 2.5 ml bupivacaine 0.5%, 15 IU hyaluronidase/ml and 0.125 ml isotonic saline)
Trial: 12027856
Drug: Group LB
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group LB (2.5 ml lignocaine 2%, 2.5 ml bupivacaine 0.5% and 0.125 ml isotonic saline)
Trial: 12027856
Drug: Group LBpH
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group LBpH (2.5 ml lignocaine 2%, 2.5 ml bupivacaine 0.5% and 0.125 ml sodium bicarbonate 8.4%)
Trial: 12027856
Drug: Group LBHpH
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group LBHpH (2.5 ml lignocaine 2%, 2.5 ml bupivacaine 0.5%, 15 IU hyaluronidase/ml and 0.125 ml sodium bicarbonate 8.4%)
Trial: 1822997
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg ISD (isosorbide dinitrate)
Trial: 111104
Drug: 1000 mg
RxNorm normalized name: bran 1000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1000 mg of slow-release xantinol nicotinate (XN) twice daily for 12 weeks
Trial: 19819667
Drug: Subcutaneous morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous morphine with 150U of recombinant human hyaluronidase (rHuPH20)
Trial: 19819667
Drug: Subcutaneous morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous morphine without recombinant human hyaluronidase (rHuPH20)
Trial: 15494907
Drug: Intravenous ribavirin
RxNorm normalized name: Ribavirin
DrugBank: Ribavirin (DB00811)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intravenous ribavirin (33 mg/kg followed by 16 mg/kg every 6 h for 4 days and 8 mg/kg every 8 h for 3 days)
Trial: 15494907
Drug: Placebo (administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (administered for 7 days or until negative Sin Nombre virus antibody test)
Trial: 11069502
Drug: UVA sunbed
RxNorm normalized name: UVA URSI
FDA approved: no
EMA approved: no
PMDA approved: no
Description: UVA sunbed treatment
Trial: 8443028
Drug: metoprolol-Oros 14/190
FDA approved: no
EMA approved: no
PMDA approved: no
Description: metoprolol-Oros 14/190 once daily
Trial: 8443028
Drug: propranolol 80
RxNorm normalized name: propranolol 80 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: propranolol 80 mg twice daily
Trial: 8443028
Drug: temazepam 10
RxNorm normalized name: temazepam 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: temazepam 10 mg once daily
Trial: 3533085
Drug: indoprofen 200
RxNorm normalized name: Neoprofen
DrugBank: Ibuprofen (DB01050)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: indoprofen 200 mg
Trial: 27187447
Drug: Q‐Mix (1000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Q‐Mix (1000 mg quercetin, 400 mg isoquercetin, 120 mg EGCG, 400 mg n3‐PUFAs, 1000 mg vitamin C, 40 mg niacinamide, 800 µg folic acid)
Trial: 22554876
Drug: Early postoperative
RxNorm normalized name: benzyl alcohol
DrugBank: Benzyl alcohol (DB06770)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Early postoperative physical therapy protocol (passive elevation and rotation starting at postoperative day 2)
Trial: 22554876
Drug: Delayed postoperative
RxNorm normalized name: povidone-iodine
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Delayed postoperative physical therapy protocol (passive elevation and rotation starting at 6 weeks)
Trial: 19468821
Drug: Urinary excretion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Urinary excretion of amino acids
Trial: 16549375
Drug: Clopidogrel (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clopidogrel (300 mg loading dose, followed by 75 mg daily for 30 days)
Trial: 15298642
Drug: Rapid immunochromatographic
RxNorm normalized name: Abreva Rapid Pain Relief
DrugBank: Glycerin (DB09462)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rapid immunochromatographic stool test before treatment
Trial: 15298642
Drug: Rapid immunochromatographic
RxNorm normalized name: Abreva Rapid Pain Relief
DrugBank: Glycerin (DB09462)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rapid immunochromatographic stool test after treatment
Trial: 11380832
Drug: losartan 50
RxNorm normalized name: LOSARTAN 50MG TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: losartan 50 mg q.d. added to lisinopril 40 mg q.d. and other antihypertensive therapy
Trial: 11380832
Drug: lisinopril 40
RxNorm normalized name: lisinopril 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: lisinopril 40 mg q.d. and other antihypertensive therapy
Trial: 3433015
Drug: Pentagastrin infusion
RxNorm normalized name: pentagastrin
DrugBank: Pentagastrin (DB00183)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pentagastrin infusion (0.9 micrograms/kg/h, intravenously)
Trial: 29732223
Drug: Mesh nebulizer
RxNorm normalized name: Aura Portaneb Mesh Nebulizer
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mesh nebulizer with salbutamol inhalation solution (0.2 ml for children ≧ 2 years old)
Trial: 29732223
Drug: Jet nebulizer
RxNorm normalized name: Pari LC Jet Nebulizer Plus RE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Jet nebulizer with salbutamol inhalation solution (0.2 ml for children ≧ 2 years old)
Trial: 29732223
Drug: Mesh nebulizer
RxNorm normalized name: Aura Portaneb Mesh Nebulizer
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mesh nebulizer with salbutamol inhalation solution (0.1 ml for children < 2 years old)
Trial: 29732223
Drug: Jet nebulizer
RxNorm normalized name: Pari LC Jet Nebulizer Plus RE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Jet nebulizer with salbutamol inhalation solution (0.1 ml for children < 2 years old)
Trial: 27757026
Drug: Vitamin E
RxNorm normalized name: Vitamin E
DrugBank: Vitamin E (DB00163)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vitamin E 50 mg/d for 5-8 years
Trial: 26482768
Drug: Androgen Deprivation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Androgen Deprivation Therapy (ADT)
Trial: 19684008
Drug: AREDS medication
RxNorm normalized name: AR-9281
DrugBank: AR-9281 (DB06345)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AREDS medication
Trial: 9282505
Drug: Sodium antimony
RxNorm normalized name: Sodium antimonyl gluconate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sodium antimony gluconate (SAG) at a dose of 20 mg/kg/day up to a maximum of 850 mg/day for 4 weeks
Trial: 9282505
Drug: Ketoconazole at
RxNorm normalized name: Ketoconazole
DrugBank: Ketoconazole (DB01026)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ketoconazole at a dose of 600 mg/day in 3 divided doses for 4 weeks
Trial: 8280551
Drug: i.v. ondansetron
FDA approved: no
EMA approved: no
PMDA approved: no
Description: i.v. ondansetron 4 mg
Trial: 23876566
Drug: Compassion‐Mindfulness Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Compassion‐Mindfulness Therapy (C‐MT)
Trial: 18662492
Drug: Duloxetine 120
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Duloxetine 120 mg QD
Trial: 18662492
Drug: Duloxetine 60-120
RxNorm normalized name: duloxetine 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Duloxetine 60-120 mg QD
Trial: 12666950
Drug: Alendronate sodium
RxNorm normalized name: Alendronate Sodium
DrugBank: Alendronic acid (DB00630)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Alendronate sodium (fosamax), one tablet every morning for six months
Trial: 11421377
Drug: Atovaquone-proguanil (AP)
RxNorm normalized name: atovaquone / proguanil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atovaquone-proguanil (AP) 1,000 mg + 400 mg once daily for 3 days
Trial: 11421377
Drug: Halofantrine (HF)
DrugBank: Halofantrine (DB01218)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Halofantrine (HF) 1,500 mg in 3 doses
Trial: 8840413
Drug: Famciclovir 500
RxNorm normalized name: famciclovir 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Famciclovir 500 mg three times daily for 7 days
Trial: 1643886
Drug: Almagate (0.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Almagate (0.25 to 0.5 mL/kg every 2 hrs by nasogastric tube)
Trial: 1643886
Drug: Ranitidine (1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ranitidine (1.5 mg/kg every 6 hrs iv)
Trial: 1643886
Drug: Sucralfate (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sucralfate (0.5 to 1 g every 6 hrs by nasogastric tube)